Patents Assigned to Texas Woman's University
  • Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents
    Patent number: 11648217
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of HAT malfunction related pathologies.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: May 16, 2023
    Assignee: Texas Woman's University
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe
  • Use of histone acetyltransferase inhibitor amidoximes as anti-proliferative agents
    Patent number: 10758501
    Abstract: Described herein is the use of bisamidoximes compounds for the treatment of cancer. In preferred embodiments, combinations of two or more bisamidoximes or combinations of a bisamidoxime and another anti-cancer agent were found to be effective against various types of cancer cells.
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: September 1, 2020
    Assignee: Texas Woman's University
    Inventors: Michael Bergel, James E. Johnson, Debra Dolliver, Sudheer Dhanireddy, Amon Gekombe